Consistent with its expression in serum, FGD5-AS1 is also highly expressed in osteosarcoma tissues and promotes osteosarcoma cell viability, invasion, and epithelial-mesenchymal transition (EMT) ability via specific binding to miR-320b [69]. The gene discussed is FGD5; the disease is osteosarcoma.